ARTELO BIOSCIENCES, INC.
8-K February 5, 2026
Key Highlights
- ARTELO secured a vital Nasdaq listing extension, preventing immediate delisting ...
- The company has until March 30, 2026, to regain compliance with Nasdaq's financi...
- ARTELO is a clinical-stage biotechnology company focused on developing cannabino...
Read Analysis
🤖 AI Generated